top of page

NanoVelcro CTC assay and Hepatocellular Carcinoma (HCC)

Our team used the NanoVelcro assay to identify the association between immunocytochemical /molecular characteristics of HCC CTCs and disease prognosis/ treatment response.

Publications

1.  M., C. C., Shuang, H., Paul, W., H., S. N., Wilda, L. Q., Yazhen, Z., A. V. (2018). A Novel Multimarker Assay for the Phenotypic Profiling of Circulating Tumor Cells in Hepatocellular Carcinoma. Liver Transplantation, 0(ja). 

NanoVelcro CTC assay and Hepatocellular Carcinoma (HCC): Research

©2018 by Translational Oncology Program. Proudly created with Wix.com

bottom of page